Press Release – New York, NY – October 31, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Algorhythm Holdings, Inc. (NASDAQ: RIME), an AI-driven technology and consumer …
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $4.2 Million Initial Public Offering of Polyrizon Ltd.
New York, NY – October 30, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as sole book running manager in the initial public offering of Polyrizon Ltd. …
Sichenzia Ross Ference Carmel LLP Represents BioSig Technologies, Inc. in $3 Million Registered Direct Offering
Press Release – New York, NY – May 30, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company committed to …
Sichenzia Ross Ference Carmel LLP Represents Genetic Technologies Limited in a $2 Million Registered Direct Offering and Concurrent Private Placement
New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”) in a $2 million registered direct …
Sichenzia Ross Ference Carmel LLP Represents Safety Shot, Inc. in a $5 Million Private Placement
Press Release – New York, NY – April 16, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Safety Shot, Inc. (Nasdaq: SHOT), the first patented beverage on Earth that helps …
Sichenzia Ross Ference Carmel LLP Represents Nature’s Miracle, Inc. in Business Combination with Lakeshore Acquisition II Corp.
Press Release – New York, NY – March 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Nature’s Miracle, Inc. (NASDAQ: NMHI) (“Nature’s Miracle” or the “Company”) as …
